ArticleOncoimmunology2021

CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma.

Kim De Veirman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.